The pheno-and genotypes of Shiga-like toxins (SLTs) in non-0157 Escherichia coli strains from patients with haemolytic uraemic syndrome were determined. The clinical isolates investigated were from Italy and Germany and belonged to serotypes 022: H8, 026 : H-, 026 : HI 1, 091 : H-, 0 1 1 1 : H-and 0128 : H-; one isolate was non-typable. SLT genotypes were analysed by complete nucleotide sequence analysis of the B-subunit genes. The results showed that 14 strains possessed slt-I alone, two contained slt-II alone and five isolates harboured both slt-I and slt-ZI genes. In only two strains were slt-11-related genes found, together with either slt-Z or slt-II. These findings indicate that variants of SLT-I1 are rarely found in non-0157 E. coli isolates from patients with haemolytic uraemic syndrome. Polymerase chain reaction (PCR) with Taq cycle sequencing was found to be a suitable method for classification of slt genotypes.
Introduction
Haemolytic uraemic syndrome (HUS) is the leading form of acute renal failure in children. Among the various forms of HUS, the classical one, which typically follows a prodrome of acute gastroenteritis, is the most frequent. Shiga-like toxin (SLT, verocytotoxin)-producing Escherichia coli strains are recognised as the major cause of this disease.' Many serogroups of E. coli other than 0157 have been implicated in sporadic cases of HUS.lP9 The first outbreak of HUS associated with non-0157 SLTproducing E. coli has been described recently." Serotyping revealed that the isolates belonged to serotype 0 1 1 1 : H-.
Immunological and molecular analysis of the SLTs produced by E. coli have shown that, in addition to the prototypes SLT-I and SLT-11, variants of SLT-I1 exist both in E. coli 0157 and non-0157 strains." SLT-11-related toxins exhibit only partial serological crossreactivity with SLT-I1 and are less toxic to HeLa cells than to Vero cells. The genes for the variants of SLT-I1 associated with human diseases are termed slt-IIc,12 ~lt-IIvhc,'~ slt-1Iva,l4 vtx2ha and vt~2hb.I~ Recently, additional SLT-I1 variants have been described, Received 14 Oct. 1994; accepted 23 Dec. 1994.
t Correspondence should be sent to Professor H. Karch. suggesting great heterogeneity among the toxins belonging to the SLT-I1 family. 16 ." Because there is insufficient nucleotide heterogeneity within the slt-II locus to permit detection of variants with polynucleotide probes, SLT-I1 variants were previously undetectable. We have demonstrated the impact of polymerase chain reaction (PCR) technology and subsequent restriction endonuclease analysis by finding slt-II-related genes among 17 of 38 strains of E. coli 0157 from patients with HUS.'* Little is known about the association between SLT-I1 variants of non-0157 E. coli strains and disease or their prevalence in E. coli strains isolated from defined diseases such as HUS. Therefore, in this study, the slt genotypes were determined in non-0157 E. coli strains associated with HUS and the combination of PCR technology with the Taq cycle sequencing method was examined for the rapid and precise classification of slt genes.
Material and methods

Bacterial strains
The 23 non-0 157 E. coli strains investigated in this study are listed in table I. All strains were isolated from HUS patients in Germany during 1985-1992 or in Italy during 1989-1993. Some of these strains have The primers and PCR conditions used to specifically amplify slt genes are given in table 11. Bacterial DNA was prepared by incubating 10 pl of a bacterial suspension (lo4 bacteria) for 10 min at 95°C. Amplifications were performed in a total volume of 50 pl containing 200 p~ deoxynucleoside triphosphates (dATP, dCTP, dGTP and dTTP), 30pmol of each primer, 5 pl of 10-fold concentrated polymerase Southern hybridisation and digoxigenin labelling of the slt-IIprobes by PCR Southern hybridisation was performed as described p r e v i~u s l y .~~ Briefly, labelled slt-IIB probes were generated with Tag-DNA-polymerase by specifically primed incorporation of digoxigenin-1 1 -dUTP during PCR. Generation of digoxigenin-labelled probes was performed in a total volume of 50 pl containing dATP, dCTP and dGTP at 2 0 0 p~, a mixture comprising 1 30 p~ dTTP and 70 p~ digoxigenin-1 1 -deoxyuridinetriphosphate (Dig-1 1 -dUTP), 30 pmol each of primer GK3 and GK4, 5pl of 10-fold concentrated polymerase synthesis buffer and 2.5 U of Taq-DNApolymerase.
Restriction endonuclease analysis
After PCR amplification with primers GK3/GK4, restriction endonuclease analysis of the products was performed with HaeIII and FokI to distinguish between slt-IIB and slt-IIB-related sequences. Briefly, 10-pl volumes of the amplified products were digested with HaeIII and FokI as recommended by the suppliers (Boehringer GmbH, Mannheim, Germany). The DNA fragments from restriction endonuclease digestion were separated and visualised as described above. Based on the published sequences of slt-IIB and slt-IIcB,12 restriction endonuclease digestion of the slt-IIB PCR product with FokI should yield two fragments of 115 bp and 155 bp, whereas the slt-IIcB PCR product should remain undigested. Conversely, restriction endonuclease digestion of the slt-IIBrelated amplification product with HaeIII should yield a 128-bp and a 142-bp fragment. The small fragments (116 bp and 154 bp; 128 bp and 142 bp) were not separable in this gel system.
Nucleotide sequence analysis by Taq cycle sequencing
Before sequence analysis, digestion of the PCR products was performed with FokI or HaeIII, which selectively digested slt-IIB and slt-IIB-related genes, respectively, and the process was repeated to eliminate any small quantities of undigested slt-11 or slt-IIBrelated genes. Gel slices with the digested fragments were excised and the DNA was purified with the Prep-A-Gene kit as described by the manufacturer (BioRad, Munich, Germany). A total of 2pg of the doublestranded PCR product was subjected to Taq cycle sequencing reactions with the Prism Ready Reaction DyeDeoxy Terminator Cycle Sequencing kit (Applied Biosystems, Darmstadt, Germany). Briefly, 9.5 pl of terminator premix, 2 pg of template DNA, 3.2 pmol each of primer GK3 and GK4 were mixed in a 0-6-ml reaction tube and made up with distilled water to a final volume of 2 0 4 . The tubes were placed in a thermal cycler preheated to 96°C and subjected to 25 cycles with the following parameters : 96°C for 15 s, 52°C for 15 s and 60°C for 4 min. The cycle sequencing products were extracted with phenol-chloroform and precipitated with ethanol. The resulting DNA pellets were dissolved in 4 ml of a mixture of formamide and 50 mM EDTA, pH 8.0, (5 : 1). Separation of sequencing products was performed on denaturing polyacrylamide 7% gels in an automatic sequencer (Model 373 A, Applied Biosystems). Nucleotide sequencing was performed in triplicate and analysed with the DNASIS program, version 2-0 from Hitachi Software (San Bruno, CA, USA). To overcome sequencing mistakes generated by Taq-DNA-polymerase, both strands of the PCR products were analysed with primers GK3 and GK4 as sequencing primers.
Cytotoxicity test and neutralisation assay
Culture filtrates were tested for cytotoxic activity on Vero cells19 and neutralisation assays25 were performed as described previously.
Results
PCR strategy and restriction fragment length polymorphism for genotyping SL Ts
To subdivide the 23 E. coli strains according to their slt genes, each isolate was subjected to PCR analysis with the primers listed in table 11. No PCR product was obtained with the primer pairs FKl/FK2, FK5/FK6 and FK7/FK8. However, 20 of the 23 E. coli strains showed a positive PCR result with the slt-IB-specific primer pair KS7/KS8. Nine of the 23 isolates yielded a positive PCR result with primers GK3/GK4 that identify both slt-IIB and the related subunit genes slt-IIcB, vtx2haB and vtx2hbB. Five of these nine isolates were of E. coli serotype 0 1 11 : H-, one was E. coli 022 : H8, one was E. coli 0128 : H-, one was E. coli 026 : H11 and one strain was not typable. The PCR products of these nine isolates analysed on agarose gels yielded DNA bands of c. 270 bp.
Restriction endonuclease analysis
For further characterisation, the 270-bp DNA bands of the nine isolates were subjected to restriction endonuclease analyses with HaeIII and FokI, which selectively digest slt-Il-related genes and slt-11, respectively. Fig. 1 , lanes 1-6, shows representative fragment patterns resulting from digestion with FokI, and lanes 7-12 with HaeIII. It can be seen that the PCR products of four isolates were digested with FokI into two smaller fragments ( fig. 1, lanes 1, 3,4 and 6) . The digestion patterns of these PCR products with HaeIII are depicted in fig. 1, lanes 7,9, 10 and 12. The PCR fragment of only the E. coli 022:H8 strain 469/87 remained undigested with FokI ( fig. 1, lane 2) , but was digested with HaeIII ( fig. 1, lane 8) . Fig. 1 , lanes 5 and 11, shows both digested and undigested fragment bands for the PCR products of strain 199/92 (lanes 1-6) or Hue111 (lanes 7-12) resulting from restriction endonuclease digestion with FokI and HaeIII, respectively. Overall, it was predicted from these restriction endonuclease analyses that the PCR products consisted of slt-IIB in seven strains, slt-IIB-related genes in one strain, and a mixture of slt-11 and slt-II-related genes in the other.
Southern blot h y br idisat ion
In addition to restriction endonuclease analyses, Southern hybridisation of genomic DNA from all nine strains possessing slt-11 or slt-II-related genes was performed with the slt-IIB probe. DNA samples from the non-toxigenic E. coli C600 and the slt-I-expressing strain E. coli C600 (H19J) were included as negative controls. In the positive control strain E. coli C600 (933W), which harbours slt-11, a single EcoRI fragment of 4.6 kb hybridised with the slt-IIB probe. The other positive control strain, which possesses slt-IIc, showed a fragment of 4.9 kb when hybridised with the slt-IIB probe. In EcoRI-digested DNA of strain 469/87, a single fragment of 3.9 kb hybridised. In contrast, seven E. coli strains (7042/87, 928/9 1, 472/92, E-D31, E-D142, E-D147 and 284/89) demonstrated a single fragment of 4.6 kb. In genomic DNA of strain 199/92, two EcoRI fragments of 3.9 kb and c. 7 kb hybridised with the probe. This is consistent with the presence of two genes belonging to the slt-11 family.
Nucleotide sequence analysis by the Taq cycle sequencing method
To definitively subtype the B-subunit genes, the fragments resulting from PCR with primers KS7/KS8 and GK3/GK4 were subjected to nucleotide sequence analysis. Before sequence analysis, the PCR product obtained from amplification with the primer pair GK3/GK4 was digested with FokI and HaeIII, as described above. The undigested fragments consisting of pure slt-11 or slt-IIB-related genes were subjected to nucleotide sequence analysis. Comparing the sequences present in the 23 E. coli strains, 100% homology with slt-IB or slt-IIB was revealed in all strains. Two strains possessed slt-IIB-related genes in addition to slt-IB or slt-IIB ( fig. 1, table I ). The Bsubunit genes of these strains possessed sequences that differed in three nucleotide bases from slt-IIcB but were identical to the published13 slt-IIvhcB sequence (fig-2 ).
Cytotoxic activity and neutralisation assay
To determine whether the slt genes were expressed, and if genotyping correlated with current immunological SLT detection methods, all strains were subjected to cytotoxicity assays and the neutralisation test. When culture supernates were tested for cytotoxicity, all 23 E. coli isolates yielded similar cytotoxic activity ( 104-106 CDSO/ml of culture supernate). However, in the two strains expressing SLT-IIvhc, the cytotoxic activity was not neutralised by antibodies against SLT-I or SLT-I1 or both.
Discussion
Shiga-like toxin (SLT)-producing E. coli strains are increasingly recognised as human pathogens causing a wide spectrum of illness including HUS. The great importance for public health lies in the fact that HUS leads to irreversible renal failure in a number of patients, necessitating dialysis or renal transplantation with the concomitant risks. The non-0157 E. coli strains isolated from patients with HUS belong to several different serogroups, E. coli 0 1 11 being predominant among the isolates from Italy and Germany. Both E. coli 0157 and non-0157 strains have been shown to produce one or both of the two prototype SLTs-SLT-I and SLT-11. Much attention has been addressed previously to variant forms of SLT-I1 which were first characterised on a molecular basis in the E. coli 091:H21 strain B2F1 associated with HUS. 15 More recently, SLT-I1 variants have been described in an E. coli 0 1 11 strain from a patient with H U S 7 and in an E. coli OX3 strain isolated from a case of sudden infant death syndrome. 16 Recent epidemiological studies have verified the frequent presence of SLT-II-related toxins among E. coli 0157 isolates. 18.26.27 In this study, non-0157 E. coli isolates from patients with HUS were investigated to analyse the variability within the slt-11 locus and to determine the prevalence of slt-11 variants. The findings demonstrated that all strains had classical slt-I or slt-11, or both. Only two strains harboured slt-IIrelated genes and these were found together with either slt-I or slt-II. Even taking into account the small sample size, the infrequent detection of slt-11 variants argues against the idea that these variants represent an important toxin component in non-0 157 E. coli.
Comparison of the nucleotide sequences of the B subunit genes of the SLT-I1 variants with published sequences revealed 100 O h homology to slt-IIvhcB, a gene which was first described in E. coli 0157: H7 strain 7279. 13 The Taq cycle sequencing method, which takes advantage of thermostable DNA polymerase, was found to be a potentially attractive method for precise genotyping of the genes belonging to the slt-11 family. However, if Taq-polymerase-mediated sequencing is performed before sequence analysis, digestion of the PCR products with FokI and HaeIII must be performed to exclude sequence errors due to the simultaneous presence of slt-II-and slt-II-related genes in the PCR products. Because of its automation and its reduced template requirement, this method can be recommended for large-scale sequencing of slt genes in clinical isolates.
Other isolates of the three serogroups (091, 0 1 11, 0128) analysed here have been slt genotyped by other investigators, 14, 1 5 9 and have yielded different results. InE. coli0128:B12 strain H.I.8, slt-IIva was identified and shown to have the greatest divergence from slt-II described to date.14 The A-subunit gene exhibits 69.5 YO, and the B-subunit gene 78.1 O/ O nucleotide sequence homology to the corresponding genes of slt-II. We were unable to identify slt-IIva in E. coli 0128 strain 284/89, even with the use of primers specific for slt-ZZvaB. Interestingly, the B-subunit gene of the E. coli 0128 isolate analysed in the present study possessed 100 YO homology to slt-IIB sequences. Paton et al. recently reported an E. coli 0111 isolate from a patient with HUS that produced an SLT-I1 variant." In this study, E. coli 0 1 11 : H-was the most frequent non-0 157 serotype associated with sporadic cases of HUS, being found in 12 of 23 isolates. However, slt-IIrelated genes were not detected in any of these strains. Ten of the 15 E. coli 0 1 11 strains had only slt-I sequences. In the remaining five strains, slt-I was present with a toxin gene that had 100 O h homology with the slt-IIB gene. Therefore, it is most likely that the toxin present in the E. coli 0 1 11 strains sequenced in our study was SLT-11. Additional SLT-II-related toxins with the greatest nucleotide sequence homology to slt-II have been shown to be present in E. coli 091 : H21 strain B2F1.15 Two variant forms of slt-II,
